Transform Wealth LLC Has $13.60 Million Holdings in McKesson Co. (NYSE:MCK)

Transform Wealth LLC increased its holdings in shares of McKesson Co. (NYSE:MCK - Free Report) by 13.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 23,828 shares of the company's stock after purchasing an additional 2,798 shares during the period. Transform Wealth LLC's holdings in McKesson were worth $13,595,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Segment Wealth Management LLC grew its stake in shares of McKesson by 1.2% during the fourth quarter. Segment Wealth Management LLC now owns 31,628 shares of the company's stock valued at $18,025,000 after acquiring an additional 366 shares in the last quarter. Perpetual Ltd grew its stake in McKesson by 13.5% during the 4th quarter. Perpetual Ltd now owns 1,937 shares of the company's stock valued at $1,104,000 after purchasing an additional 230 shares in the last quarter. Charles Schwab Trust Co purchased a new stake in McKesson during the 4th quarter worth approximately $349,000. Aspiriant LLC acquired a new position in shares of McKesson in the 4th quarter valued at approximately $235,000. Finally, Pure Financial Advisors LLC grew its position in shares of McKesson by 3.3% during the fourth quarter. Pure Financial Advisors LLC now owns 792 shares of the company's stock worth $452,000 after buying an additional 25 shares in the last quarter. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on MCK shares. Wells Fargo & Company boosted their price target on McKesson from $535.00 to $641.00 and gave the company an "equal weight" rating in a report on Friday, December 13th. Bank of America reduced their price target on shares of McKesson from $680.00 to $650.00 and set a "buy" rating for the company in a report on Monday, January 6th. Evercore ISI lifted their price objective on shares of McKesson from $560.00 to $680.00 and gave the company an "outperform" rating in a research report on Thursday, November 7th. StockNews.com upgraded shares of McKesson from a "hold" rating to a "buy" rating in a research note on Wednesday, November 6th. Finally, Leerink Partners cut their price target on McKesson from $665.00 to $630.00 and set an "outperform" rating on the stock in a report on Monday, October 7th. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, McKesson presently has an average rating of "Moderate Buy" and an average target price of $646.14.

Insiders Place Their Bets

In other news, EVP Leann B. Smith sold 579 shares of the stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $572.79, for a total value of $331,645.41. Following the completion of the sale, the executive vice president now directly owns 864 shares of the company's stock, valued at $494,890.56. This represents a 40.12 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.11% of the company's stock.

McKesson Trading Down 1.6 %

MCK stock traded down $9.28 during trading hours on Tuesday, hitting $583.29. 505,394 shares of the stock traded hands, compared to its average volume of 633,292. The stock has a 50-day simple moving average of $594.65 and a 200 day simple moving average of $561.08. The company has a market cap of $74.04 billion, a P/E ratio of 30.18, a P/E/G ratio of 1.28 and a beta of 0.52. McKesson Co. has a one year low of $464.42 and a one year high of $637.51.

McKesson (NYSE:MCK - Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $7.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $6.88 by $0.19. McKesson had a negative return on equity of 207.50% and a net margin of 0.77%. The company had revenue of $93.65 billion for the quarter, compared to analyst estimates of $89.33 billion. During the same period in the previous year, the firm earned $6.23 earnings per share. McKesson's revenue for the quarter was up 21.3% compared to the same quarter last year. Analysts forecast that McKesson Co. will post 32.73 earnings per share for the current year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Monday, December 2nd were paid a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a yield of 0.49%. The ex-dividend date was Monday, December 2nd. McKesson's dividend payout ratio is 14.71%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.